Surgery, Abdominal Transplant Surgery
-
-
Administers Grant
-
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR PREVENTION OF DELAYED GRAFT FUNCTION IN RECIPIENTS OF A DONATION AFTER BRAIN DEATH OLDER DONOR KIDNEY TRANSPLANT (ReGIFT)
-
A Prospective, Open-Label, Long-Term Safety and Efficacy of Teduglutide
-
A multi-center, randomized double-blind, three-arm, parallel-group trial to assess the efficacy and safety of NTRA-9620 in infants with short bowel syndrome (SBS) following surgical resection
-
A multicenter randomized, controlled trial to compare the efficacy of ex-vivo normothermic machine perfusion with static cold storage in human liver transplantation
-
A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
-
A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function
-
Allo Vir ALVR105
-
Antibody and B cell kinetics following IdeS (Imlipidase) administration in a sensitized non-human primate model
-
BMS-EnList
-
CD57+CD4+ T cells in Belatacept-resistant Renal Allograft Rejection
-
Developing clinically relevant immunosuppressive regimen for pig to rhesus kidney transplantation using transgenic pigs
-
EP396: HLA Reporter Cell Lines for Desensitization Trials
-
EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)
-
Effects of storage method on intestinal allograft immune profile and viability
-
Gene therapy of discarded human kidney grafts during 48 hours ex-vivo machine perfusion
-
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
-
Hansa Ph3 Deceased Donor Kidney Transplant Study - SAB-HAL/Central XM Analysis
-
IM101-823 - Abatacept for treatment of recurrent or de novo autoimmune hepatitis
-
Improving Racial Equity in Clinical Decision Making about Access to Organ Transplant
-
Living Donor Kidney Transplant: Establishing the Phenotype of an Equitable Program
-
Lung Transplant Plasmapheresis (PLEX)/Belatacept/Carfilzomib Protocol for Treatment of Antibody Mediated Rejection (AMR) and Desensitization
-
Phase2 Prospective, Multi-center, Open-label, Controlled Trial to Assess the Safety and Efficacy
of Cellular Immunotherapy with MDR-103 for Induction of Mixed Chimerism and Immune
Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kid
-
Promoting humoral tolerance via targeting complement C3
-
Prospective, Randomized, Controlled, Multicenter, Multi-National, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of HEMOBLASTTM Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries
-
STARS Extension Study
-
Sample Collection for Prospera Enhancement by Detecting dd-cfDNA Levels (PEDAL Study)
-
Short Bowel Syndrome Registry
-
Targeting complement C2 in a sensitized rat cardiac allograft model
-
Targeting complement C3 to prevent acute antibody-mediated rejection for a deceased-donor kidney transplant in sensitized recipients
-
Targeting complement activation steps in antibody-mediated rejection
-
The Delivery of AAV Vector to Liver Allograft using Machine Perfusion System
-
The Risks and Opporunities of Homeostatic Repopulation
-
Transplant Genomics - TruGraf testing
-
Transplant Tolerance in Non-Human Primates
-
Transplant Tolerance in Non-Human Primates
-
Use of Sirtuin-1 Activators to Mitigate Ischemia-Reperfusion Injury after Liver Transplantation